Wellington Management Group LLP Veracyte, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Veracyte, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 4,232,844 shares of VCYT stock, worth $173 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,232,844

Previous 6,876,184 38.44%

Holding current value

$173 Million

Previous $149 Million 3.33%

% of portfolio

0.03%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$21.0 - $35.25 $55.5 Million - $93.2 Million	-2,643,340 Reduced 38.44%	4,232,844 $144 Million
Q2 2024 Aug 13, 2024	SELL	$18.86 - $23.55 $9.27 Million - $11.6 Million	-491,279 Reduced 6.67%	6,876,184 $149 Million
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $155 Million - $214 Million	7,367,463 New	7,367,463 $163 Million
Q4 2023 Feb 12, 2024	BUY	$19.72 - $28.68 $139 Million - $203 Million	7,068,435 New	7,068,435 $194 Million
Q3 2023 Nov 14, 2023	SELL	$22.33 - $29.92 $2.33 Million - $3.13 Million	-104,556 Reduced 1.46%	7,067,864 $158 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $489,248 - $630,000	23,342 Added 0.33%	7,172,420 $183 Million
Q1 2023 May 12, 2023	BUY	$20.58 - $27.89 $10.5 Million - $14.3 Million	512,535 Added 7.72%	7,149,078 $159 Million
Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $11.9 Million - $23.2 Million	775,820 Added 13.24%	6,636,543 $157 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $146,069 - $245,799	8,810 Added 0.15%	5,860,723 $97.3 Million
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $14.5 Million - $27.7 Million	938,918 Added 19.11%	5,851,913 $116 Million
Q1 2022 May 16, 2022	SELL	$21.94 - $42.51 $3.64 Million - $7.05 Million	-165,832 Reduced 3.27%	4,912,995 $135 Million
Q4 2021 Feb 11, 2022	BUY	$36.09 - $53.79 $341,988 - $509,714	9,476 Added 0.19%	5,078,827 $209 Million
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $82.6 Million - $123 Million	2,319,050 Added 84.32%	5,069,351 $235 Million
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $21.2 Million - $36.4 Million	642,159 Added 30.46%	2,750,301 $110 Million
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $25.6 Million - $46.9 Million	-575,928 Reduced 21.46%	2,108,142 $113 Million
Q4 2020 Feb 12, 2021	SELL	$32.49 - $61.88 $49.1 Million - $93.4 Million	-1,510,099 Reduced 36.0%	2,684,070 $131 Million
Q3 2020 Nov 16, 2020	BUY	$26.73 - $35.67 $56.3 Million - $75.1 Million	2,106,167 Added 100.87%	4,194,169 $136 Million
Q2 2020 Aug 14, 2020	BUY	$19.49 - $28.11 $21.8 Million - $31.4 Million	1,116,200 Added 114.86%	2,088,002 $54.1 Million
Q1 2020 May 14, 2020	BUY	$16.13 - $30.17 $3.24 Million - $6.06 Million	200,699 Added 26.03%	971,802 $23.6 Million
Q4 2019 Feb 11, 2020	BUY	$20.78 - $29.99 $16 Million - $23.1 Million	771,103 New	771,103 $21.5 Million

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.93B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Veracyte, Inc. Transaction History